Understanding Equine Herpesvirus-1 (EHV-1) Pathophysiology
Equine Herpesvirus-1 is a widespread pathogen that affects the respiratory, reproductive, and neurological systems of equines. It is a double-stranded DNA virus that, once introduced to a premise, can persist in the environment and establish latency within the horse population.
Clinical Syndromes Associated with Alphaherpesvirinae
The infection typically manifests in one of three ways: respiratory disease, equine viral abortion, or the neurological form known as Equine Herpesvirus Myeloencephalopathy (EHM). While Equine Influenza is often the first concern with respiratory outbreaks, EHV-1 possesses unique properties that allow it to bypass traditional mucosal immunity.
Clinical Manifestations and Neurological Progression
Identifying signs early is vital for containment. Owners should be vigilant for fever followed by nasal discharge, lethargy, and decreased appetite.
Warning Indicators of EHM (Emergency)
Neurological impairment is the most dreaded complication of EHV-1. Signs include hind-limb ataxia (wobbliness), bladder atony leading to urine dribbling, and weakness in the tail. If a horse shows signs of recumbency, it constitutes a medical emergency. This is often confused with Equine Infectious Anemia in regions where screening is required. Immediate isolation is necessary if these signs appear.
Diagnostic Procedures and Laboratory Confirmation
Veterinarians utilize several tools to confirm an EHV-1 infection.
Nasopharyngeal Swabs and PCR Analysis
The gold standard for diagnosis is the collection of nasopharyngeal swabs followed by polymerase chain reaction (PCR) testing. This detects the viral DNA. During active infection, veterinarians may also collect blood samples to analyze white blood cell counts, noting potential changes caused by the virus during its systemic phase.
Management and Supportive Care Protocols
There is no specific cure for EHV-1; therefore, treatment is purely supportive.
Fluid Therapy and Anti-Inflammatory Medication
Horses with neurological involvement may require intravenous fluids, non-steroidal anti-inflammatory drugs (NSAIDs) to manage fever and neuro-inflammation, and bladder management to prevent rupture. Nursing care, including padding to prevent pressure sores in recumbent horses, is critical to recovery.
Biosecurity and Herd Immunity
Preventing the spread of this virus relies on strict biosecurity protocols.
Quarantine and Vaccination Efficacy
Quarantining new arrivals for 21 days is mandatory for limiting the introduction of the pathogen. While vaccines exist, they primarily mitigate the severity of respiratory disease and shedding; they are often not fully effective against the neurological form, making management and movement restrictions the most effective tools in a veterinarian's arsenal.


